Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate
Denosumab May Help Prevent Bone Loss
Past Highlights
Results:
1 -7 of 7
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
8/1/1991
1.
Phase II Study of 5-FU/MMPR/PALA in Unresectable Adenocarcinoma of the Pancreas (Summary Last Modified 08/91)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
18 and over
NCI
FCCC-91006
NCI-T91-0037D, T91-0037
2.
Phase I Study with 6-Methylmercaptopurine Riboside/5-Fluorouracil by Continuous Infusion for Carcinoma, Sarcoma, and Leukemia
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Closed
no age specified
NCI-W82-0478
DFCI-81044
3.
Phase I Clinical and Pharmacologic Study of MMPR, PALA, and 5-FU in Patients with Advanced Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Closed
no age specified
NCI-W81-0256
Last Modified:
6/1/1997
4.
Phase I Combination Chemotherapy with PALA/MMPR/5-FU in Patients with Carcinoma and Sarcoma (Summary Last Modified 06/97)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Completed
no age specified
NCI
DFCI-82114
NCI-T83-0929D, T83-0929
Last Modified:
6/1/1997
5.
Phase I Combination Chemotherapy with MMPR/PALA/5-FU in Patients with Advanced Cancer (Summary Last Modified 06/97)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Completed
18 and over
NCI
MSKCC-87121
NCI-T87-0259C, T87-0259
6.
Phase I Study of PALA/MMPR/5-FU in Patients with Advanced Solid Tumors
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Completed
18 and over
NCI
FCCC-88967
NCI-T88-0105D, T88-0105
Last Modified:
1/1/1992
7.
Phase I Study of 5-FU with PALA/MMPR/CF in Patients with Advanced Malignancies (Summary Last Modified 01/92)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Completed
18 and over
NCI
FCCC-91056
NCI-T91-0165D, T91-0165
Select All on One Page
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute